Optinose Announces Reporting Date for Fourth Quarter 2022 Financial Results

March 1, 2023

https://www.globenewswire.com/news-release/2023/02/28/2617719/0/en/Optinose-Announces-Reporting-Date-for-Fourth-Quarter-2022-Financial-Results.html

YARDLEY, Pa., Feb. 28, 2023 (GLOBE NEWSWIRE) — Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced the Company will report financial results for the fourth quarter 2022 and corporate updates, before market open on Tuesday, March 7, 2023.

Read more at globenewswire.com

Related news for (OPTN)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.